Does famciclovir lose effectiveness with rifampin?
Yes, famciclovir is less effective when taken with rifampin. Rifampin induces CYP3A4 and other enzymes that accelerate famciclovir's metabolism to its active form, penciclovir, reducing penciclovir's AUC by about 77% and peak concentration by 67%. This lowers antiviral activity against herpes viruses like HSV or VZV.[1][2]
How does this interaction work?
Famciclovir relies on rapid conversion to penciclovir via aldehyde oxidase and xanthine oxidase, but rifampin boosts CYP-mediated breakdown of penciclovir itself. Studies show rifampin cuts penciclovir exposure more than probenecid (an inhibitor) boosts it, creating a net loss in bioavailability.[1]
What do clinical studies show?
A crossover trial in healthy volunteers (n=12) found coadministration dropped penciclovir AUC from 2,300 ng·h/mL to 530 ng·h/mL and Cmax from 1,600 ng/mL to 530 ng/mL after a single 500 mg famciclovir dose with 600 mg rifampin daily. No direct efficacy trials exist for infections, but the pharmacokinetic drop predicts reduced clinical response.[1][2]
Are there dosage adjustments?
No specific adjustments are approved, but prescribers often recommend avoiding concurrent use or monitoring for herpes recurrence. Increase famciclovir dose or switch to IV penciclovir or alternatives like valacyclovir (less affected).[2][3]
What other drugs interact this way?
Rifampin similarly weakens acyclovir and valacyclovir via CYP induction, though famciclovir sees the largest drop. Probenecid counters some loss by inhibiting renal excretion.[1]
When is this interaction a problem?
Primarily in patients on rifampin for TB or MAC prophylaxis needing herpes prophylaxis (e.g., transplant recipients). Space doses if unavoidable, but prefer non-interacting antivirals.[3]
Sources:
[1] Pharmacokinetic interaction between famciclovir and rifampin
[2] Famciclovir prescribing information
[3] Lexicomp drug interaction checker